BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

Historical Holders from Q2 2022 to Q3 2025

Symbol
BLTE on Nasdaq
CUSIP
07782B104
Type / Class
Equity / Ordinary Shares, par value US$0.0001 per share
Shares outstanding
37.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
2.29M
Holdings value
$169M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
34
Number of buys
27
Number of sells
-5
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lin Bioscience International Ltd. 53.7% $1.07B 17.1M Lin Bioscience International Ltd. Dec 31, 2024
Darwin Global Management, Ltd. 7% $294M 2.62M Darwin Global Management, Ltd. Dec 3, 2025
Lin Yu-Hsin 7.1% $142M 2.29M Yu-Hsin Lin Dec 31, 2024

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.29M $169M +$163M $74.00 34
2025 Q2 78.1K $4.51M -$5.1M $57.70 18
2025 Q1 150K $9.91M -$8.04M $66.22 18
2024 Q4 282K $17.8M +$12.8M $63.10 21
2024 Q3 78.7K $3.69M -$4.87M $46.88 15
2024 Q2 187K $8.52M +$5.98M $45.68 11
2024 Q1 58.1K $2.23M -$4.08M $38.37 11
2023 Q4 155K $7.1M +$3.53M $45.75 17
2023 Q3 99.6K $3.17M -$26.3M $31.85 7
2023 Q2 1.04M $14.9M +$2.37M $14.29 6
2023 Q1 850K $25.4M -$211K $29.90 8
2022 Q4 857K $25.9M +$22.3M $30.15 7
2022 Q3 115K $3.87M +$1.59M $33.76 8
2022 Q2 68.9K $2.15M +$2.15M $31.13 6